Loxifrit 4 Tablet contains Lornoxicam 4mg, a potent non-steroidal anti-inflammatory drug (NSAID) indicated for the management of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, and musculoskeletal disorders. It helps in relieving joint stiffness, swelling, and discomfort.
Lornoxicam works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, reducing the production of prostaglandins responsible for pain, inflammation, and fever. This mechanism ensures rapid relief and improved mobility in affected patients.
For distributors and healthcare suppliers, Loxifrit 4 Tablet is a high-demand analgesic and anti-inflammatory product, commonly prescribed by orthopedists, rheumatologists, and general physicians. The widespread prevalence of arthritis and musculoskeletal pain ensures consistent clinical demand.
Adding Loxifrit 4 Tablet to your pain management and anti-inflammatory therapy segment creates strong opportunities in pharmacies, hospitals, orthopedic clinics, export markets, and third-party manufacturing. Its proven clinical efficacy, broad therapeutic application, and strong prescriber acceptance make it a valuable addition to pharmaceutical distribution portfolios.